BANK OF AMERICA CORP /DE/ - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 62 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q1 2021$25,000
-99.2%
25,000
-99.1%
0.00%
Q4 2020$3,106,000
-21.7%
2,874,000
-26.7%
0.00%
-100.0%
Q1 2020$3,967,000
-57.5%
3,920,000
-52.0%
0.00%0.0%
Q4 2019$9,336,000
+89.8%
8,160,000
+89.2%
0.00%0.0%
Q3 2019$4,919,000
+2187.9%
4,313,000
+2269.8%
0.00%
Q2 2019$215,000
-86.9%
182,000
-85.0%
0.00%
Q1 2019$1,636,000
+23271.4%
1,210,000
+17185.7%
0.00%
Q4 2018$7,000
+16.7%
7,000
+16.7%
0.00%
Q3 2018$6,0000.0%6,0000.0%0.00%
Q2 2018$6,0000.0%6,0000.0%0.00%
Q1 2018$6,0000.0%6,0000.0%0.00%
Q4 2017$6,0000.0%6,0000.0%0.00%
Q3 2017$6,0000.0%6,0000.0%0.00%
Q2 2017$6,000
+500.0%
6,000
+500.0%
0.00%
Q1 2017$1,0000.0%1,0000.0%0.00%
Q4 2016$1,000
-98.5%
1,000
-98.6%
0.00%
Q3 2016$65,000
-97.6%
70,000
-98.2%
0.00%
-100.0%
Q2 2016$2,714,000
+90366.7%
3,840,000
+127900.0%
0.00%
Q1 2016$3,0003,0000.00%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q2 2019
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 16,935,000$17,946,697,0003.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 45,700,000$48,504,0002.18%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$21,312,0001.66%
LINDEN ADVISORS LP 34,494,000$36,562,0001.30%
WOLVERINE ASSET MANAGEMENT LLC 96,239,000$101,731,0001.13%
MACKAY SHIELDS LLC 24,155,000$25,567,0000.95%
Verition Fund Management LLC 10,200,000$10,799,0000.87%
Jabre Capital Partners S.A. 4,000,000$4,243,0000.82%
ADVENT CAPITAL MANAGEMENT /DE/ 38,030,000$40,330,0000.76%
AQR Arbitrage LLC 44,600,000$47,220,0000.51%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders